Literature DB >> 28815318

[Adrenal crisis].

S Burger-Stritt1, S Hahner2.   

Abstract

Patients with chronic adrenal insufficiency suffer from reduced quality of life and increased mortality. An association between mortality and adrenal crisis is assumed. The frequency of adrenal crisis is about 8/100 patient years. The main causes are infectious disease. Pathophysiology is poorly understood to date. An association with an exaggerated inflammatory response due to a lack of glucocorticoid modulation as well as mineralocorticoid deficiency and diminished adrenomedullary function are discussed. The therapy of adrenal crisis includes prompt parenteral administration of hydrocortisone combined with isotonic saline. To prevent adrenal crisis, patients are equipped with an emergency card and set and educated in glucocorticoid dose adjustment.

Entities:  

Keywords:  Addison’s disease; Adrenal insufficiency; Emergency, adrenal; Hydrocortisone; Infection

Mesh:

Substances:

Year:  2017        PMID: 28815318     DOI: 10.1007/s00108-017-0307-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

Review 1.  The recognition and treatment of adrenal crisis.

Authors:  A G Pazianos
Journal:  Med Clin North Am       Date:  1969-03       Impact factor: 5.456

2.  Tumor necrosis factor inhibits glucocorticoid receptor function in mice: a strong signal toward lethal shock.

Authors:  Tom Van Bogaert; Sofie Vandevyver; Lien Dejager; Filip Van Hauwermeiren; Iris Pinheiro; Ioanna Petta; David Engblom; Anna Kleyman; Günther Schütz; Jan Tuckermann; Claude Libert
Journal:  J Biol Chem       Date:  2011-06-06       Impact factor: 5.157

3.  Addison's disease with polyglandular autoimmunity carries a more than 2·5-fold risk for adrenal crises: German Health insurance data 2010-2013.

Authors:  Gesine Meyer; Klaus Badenhoop; Roland Linder
Journal:  Clin Endocrinol (Oxf)       Date:  2016-03-10       Impact factor: 3.478

4.  High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study.

Authors:  Stefanie Hahner; Christina Spinnler; Martin Fassnacht; Stephanie Burger-Stritt; Katharina Lang; Danijela Milovanovic; Felix Beuschlein; Holger S Willenberg; Marcus Quinkler; Bruno Allolio
Journal:  J Clin Endocrinol Metab       Date:  2014-11-24       Impact factor: 5.958

5.  Reduced lymphocyte beta 2-adrenoceptor density and impaired diastolic left ventricular function in patients with glucocorticoid deficiency.

Authors:  B Allolio; W Ehses; H M Steffen; R Müller
Journal:  Clin Endocrinol (Oxf)       Date:  1994-06       Impact factor: 3.478

6.  Adrenal crisis in treated Addison's disease: a predictable but under-managed event.

Authors:  Katherine White; Wiebke Arlt
Journal:  Eur J Endocrinol       Date:  2009-09-23       Impact factor: 6.664

7.  Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency.

Authors:  Stefanie Hahner; Stephanie Burger-Stritt; Bruno Allolio
Journal:  Eur J Endocrinol       Date:  2013-06-29       Impact factor: 6.664

8.  Timelines in the management of adrenal crisis - targets, limits and reality.

Authors:  Stefanie Hahner; Nina Hemmelmann; Marcus Quinkler; Felix Beuschlein; Christina Spinnler; Bruno Allolio
Journal:  Clin Endocrinol (Oxf)       Date:  2014-11-06       Impact factor: 3.478

9.  A glucocorticoid education group meeting: an effective strategy for improving self-management to prevent adrenal crisis.

Authors:  Han J W J Repping-Wuts; Nike M M L Stikkelbroeck; Alida Noordzij; Mies Kerstens; Ad R M M Hermus
Journal:  Eur J Endocrinol       Date:  2013-05-17       Impact factor: 6.664

Review 10.  Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Stefan R Bornstein; Bruno Allolio; Wiebke Arlt; Andreas Barthel; Andrew Don-Wauchope; Gary D Hammer; Eystein S Husebye; Deborah P Merke; M Hassan Murad; Constantine A Stratakis; David J Torpy
Journal:  J Clin Endocrinol Metab       Date:  2016-01-13       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.